Peter Sordillo

Hoofd Techniek/Wetenschap/O&O bij SignPath Pharma, Inc.

Consumer Services

Commercial Services

Actieve functies van Peter Sordillo

Bedrijven	Functie	Begin	Einde
SignPath Pharma, Inc. SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT.	Hoofd Techniek/Wetenschap/O&O	01-06-2017	-
Icahn School of Medicine at Mount Sinai	Corporate Officer/Principal	-	-

Bedrijven	Functie	Begin	Einde
New York University School of Medicine	Corporate Officer/Principal	-	-
Weill Cornell Medical College	Corporate Officer/Principal	-	-

Columbia College (New York)	Undergraduate Degree
New York Medical College	Graduate Degree
New York University	Graduate Degree
The Trustees of Columbia University in The City of New York	Doctorate Degree

Internationaal

Verenigde Staten

Operationeel

Graduate Degree	3
Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1

Sectoraal

Consumer Services	8
Commercial Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Bedrijven in privébezit	1
SignPath Pharma, Inc. SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT.	Commercial Services

Bedrijven in privébezit

Commercial Services